Type 2 Deiodinase Polymorphism (Threonine 92 Alanine) Predicts l-Thyroxine Dose to Achieve Target Thyrotropin Levels in Thyroidectomized Patients
Author(s) -
Massimo Torlontano,
Cosimo Durante,
Isabella Torrente,
Umberto Crocetti,
Giovanni Augello,
Giuseppe Ronga,
Teresa Montesano,
Laura Travascio,
Antonella Verrienti,
Rocco Bruno,
Stefano Angelo Santini,
P D'Arcangelo,
Bruno Dallapiccola,
Sébastiano Filetti,
Vincenzo Trischitta
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-1067
Subject(s) - deiodinase , medicine , threonine , endocrinology , alanine , chemistry , thyroid , biochemistry , enzyme , thyroid hormones , amino acid , serine
Type 2 deiodinase (D2) converts T4 in T3 in several human tissues, including hypothalamus and pituitary, and, therefore, plays a pivotal role in the negative feedback regulation of TSH secretion. A common variant of the gene, threonine (Thr) 92 alanine (Ala), has been identified and associated with decreased D2 enzymatic activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom